Qingchun Zeng
-
- Cardiac Valve Diseases and Treatments 19
- Cardiovascular Function and Risk Factors 17
- Heart Failure Treatment and Management 10
- Blood Pressure and Hypertension Studies 6
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 7
- Immunology top 10%
- Nephrology top 5%
- Molecular Biology top 10%
-
- Aortic Disease and Treatment Approaches 7
-
- Autophagy in Disease and Therapy 7
-
- Acute Myeloid Leukemia Research 6
- Journals
- Circulation (1 paper)SHILAP Revista de lepidopterología (1 paper)Journal of the American College of Cardiology (3 papers)
- Partner nations
- ChinaUnited StatesAfghanistan
In The Last Decade
Qingchun Zeng
103 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 122
- Cardiology and Cardiovascular Medicine 605
- Cancer Research 219
- Immunology 305
- Nephrology 88
- Molecular Biology 835
Countries citing papers authored by Qingchun Zeng
This map shows the geographic impact of Qingchun Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingchun Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingchun Zeng more than expected).
Fields of papers citing papers by Qingchun Zeng
This network shows the impact of papers produced by Qingchun Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingchun Zeng. The network helps show where Qingchun Zeng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qingchun Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 6 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 72 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 23 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 80 | |
| 15 | 2020 | 2 | |
| 16 | 2019 | 7 | |
| 17 | 2018 | 46 | |
| 18 | 2014 | 4 | |
| 19 | 2014 | 20 | |
| 20 | 2009 | 10 |
About Qingchun Zeng
Qingchun Zeng is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Nephrology, having authored 113 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (19 papers), Cardiovascular Function and Risk Factors (17 papers), Heart Failure Treatment and Management (10 papers), Cancer-related molecular mechanisms research (7 papers), Aortic Disease and Treatment Approaches (7 papers), Autophagy in Disease and Therapy (7 papers), Acute Myeloid Leukemia Research (6 papers) and Blood Pressure and Hypertension Studies (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (605 citations), Cancer Research (219 citations) and Immunology (305 citations). Qingchun Zeng has collaborated with scholars based in China, United States and Afghanistan. Frequent co-authors include Dingli Xu, Xianzhong Meng, Lihua Ao, Hao Ren, David A. Fullerton, Qiong Zhan, Wenyan Lai, Zuheng Liu, Rui Song and Joseph C. Cleveland. Their work appears in journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.